The latest research from Fore Pharma, Germany Congestive Heart Failure Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Congestive Heart Failure pipeline products, Congestive Heart Failure epidemiology, Congestive Heart Failure market valuations and forecast, Congestive Heart Failure products sales and competitive landscape in Germany.
The research is classified into nine sections – Congestive Heart Failure overview including etiology, pathophysiology, and diagnosis, Congestive Heart Failure treatment options, Congestive Heart Failure pipeline products, Congestive Heart Failure market analysis comprising of Congestive Heart Failure epidemiology, key products marketed for Congestive Heart Failure, market valuations and forecast, products sales and market shares.
Research Scope: - Congestive Heart Failure Pipeline: Find out the products in clinical trials for the treatment of Congestive Heart Failure by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products - Congestive Heart Failure Epidemiology: Find out the number of patients diagnosed (prevalence) with Congestive Heart Failure in Germany - Congestive Heart Failure Products: Identify key products marketed and prescribed for Congestive Heart Failure in Germany, including trade name, molecule name, and company - Congestive Heart Failure Product Sales: Find out the sales revenues of Congestive Heart Failure products, both branded and generics, in Germany - Congestive Heart Failure Market Valuations: Find out the market size for Congestive Heart Failure products in 2015 in Germany. Find out how the market advanced from 2010 and forecast to 2020 - Congestive Heart Failure Products Market Share: Find out the market shares for key Congestive Heart Failure products in Germany
Benefits of this Research: The research helps executives to - Support monitoring and reporting national Congestive Heart Failure market analysis and sales trends - Track competitor drugs sales and market share in Germany Congestive Heart Failure market - Track competitive developments in Congestive Heart Failure market and present key issues and learnings - Synthesize insights for Congestive Heart Failure market and products to drive business performance - Answer key business questions about the Congestive Heart Failure market - Evaluate commercial market opportunity assessment, positioning, and segmentation for Congestive Heart Failure products - Supports decision making in R&D to long term marketing strategies
Our reports have been used by over 10K customers, including:
Omega 3 Supplements Market Size, Share & Trends Analysis Report By Source (Fish Oil, Krill Oil), By Form (Soft Gels, Capsules), By Functionality, By End-user, By Distribution Channel, By Region, And Segment Forecasts, 2020 - 2027
Omega 3 Supplements Market Growth & Trends
The global omega...
KEY FINDINGS The global anticoagulants market is estimated to project a CAGR of 8.42% during the forecast period of 2021 to 2028. The key market growth drivers include, the surging approval of novel oral anticoagulants (NOAC), technical advancements, and the surging incidence of chronic diseases. MARKET INSIGHTS Anticoagulants...
Summary SomaLogic Inc (SomaLogic) is a life science company that discovers, develops and commercializes life science research tools and clinical diagnostic products.The company’s products include SOMAscan assay and SOMAmer reagents. Its SOMAscan reagents is a proteomic platform that combines the properties of antibodies...
KEY FINDINGS The Asia Pacific cartilage repair market is estimated to project a CAGR of 16.84% during the forecast period, 2021-2028. The increasing need for sophisticated medical facilities, the growing prevalence of lifestyle diseases resulting in bone & joint ailments, and the rising R&D activities, are propelling the...
KEY FINDINGS The Europe anticoagulants market is expected to record a CAGR of 8.48%, over the forecast period of 2021 to 2028. The region’s market growth is accredited to the rise in healthcare expenditure, the growing prevalence of venous thromboembolism (VTE) and atrial fibrillation, the increase in the geriatric and...
200 pages •
By The Business Research Company
• Dec 2020
Major players in the erythropoietin (EPO) market are Amgen Inc., Johnson & Johnson, Roche Group, Pfizer Inc., Novartis, Celltrion Inc and LG Life Sciences Ltd. The global erythropoietin (EPO) market is expected to decline from $1.01 billion in 2019 to $0.95 billion in 2020 at a compound annual growth rate (CAGR) of -6.27%. The decline...
The Europe electronic skin patches market is registered to project a CAGR of 16.41%, during the forecast years of 2021 to 2028. The region’s key market growth drivers are, the surging number of research and development activities, the rising healthcare expenditure, and the increasing geriatric population.
KEY FINDINGS The Germany fish oil market is expected to register a CAGR of 8.14% in terms of volume, and 9.92% in terms of revenue, during the forecast years. The increased demand for tailor-made omega-3 products and the rising health awareness concerning chronic diseases, predominantly drive the country’s fish oil market....
17 pages •
By Euromonitor International
• Nov 2020
After peaking in 2024, depopulation will occur in Germany up to 2040 as falling net migration rates are no longer able to mitigate increasingly negative natural change. As birth rates drop and longevity climbs, ageing will accelerate transforming consumer trends and putting additional pressure on state resources. Urbanisation will continue...
The Europe 3D Ultrasound Market would witness market growth of 8% CAGR during the forecast period (2020-2026). The driving elements for the development of the ultrasound devices market incorporate the government and private subsidizing for R&D in ultrasound imaging, an expanding number of medical care suppliers, development in technology,...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.